High level dynein impairs mitochondrial distribution and differentiation of rhabdomyosarcoma cells

Ting-Ling Ke1, Linyi Chen1,2

  • 1Institute of Molecular Medicine, National Tsing Hua University, No. 101, Section 2, Kuang-Fu Road, Hsinchu 30013, Taiwan.

Iscience
|June 3, 2026
PubMed

Insights

Mitochondrial defects in rhabdomyosarcoma cells impair muscle development. Restoring mitochondrial transport via MYO19 or dynein inhibition can partially rescue myogenic differentiation, revealing key disease mechanisms.

Area of Science:

  • Cell Biology
  • Muscle Development
  • Mitochondrial Dynamics

Background:

  • Rhabdomyosarcoma-derived RD and RH30 cells exhibit defective myogenesis.
  • These cells display enlarged mitochondria with perinuclear distribution.
  • Impaired mitochondrial morphology, trafficking, and activity are linked to various human diseases.

Purpose of the Study:

  • To investigate the link between mitochondrial phenotypes and physiological outcomes in rhabdomyosarcoma cells.
  • To elucidate the mechanisms underlying mitochondrial clustering and its impact on myogenesis.

Main Methods:

  • Analysis of mitochondrial morphology and distribution in RD and RH30 cells.
  • Quantification of myosin (MYO19) and dynein motor protein levels.
  • Assessment of mitochondrial transport using actin- and microtubule-based mechanisms.
  • Functional studies involving MYO19 overexpression and dynein inhibition.

Main Results:

  • RD cells showed reduced MYO19 and elevated dynein motor and MIRO1/2 adaptors.
  • Impaired anterograde actin-based transport and enhanced retrograde microtubule-based transport caused mitochondrial perinuclear clustering.
  • MYO19 overexpression partially rescued mitochondrial distribution in RD cells.
  • Dynein inhibition altered mitochondrial distribution and restored myogenic differentiation in both cell types.

Conclusions:

  • Altered mitochondrial morphology and distribution, driven by imbalanced motor protein activity, contribute to defective myogenesis in rhabdomyosarcoma.
  • Targeting mitochondrial transport pathways offers potential therapeutic strategies for rhabdomyosarcoma and related muscle disorders.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Microtubule Associated Motor Proteins01:32

Microtubule Associated Motor Proteins

Eukaryotic cells have different motor proteins for transporting various cargo within the cell. These motor proteins differ based on the filament they associate with, the direction they move within the cell, and the type of cargo they transport. Motor proteins that associate with microtubules are known as microtubule-associated motor proteins. There are two families of microtubule-associated motor proteins —Kinesins and Dyneins. Both these proteins assist in the transport of cellular cargos...
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...